Cargando…
COVID-19-induced postural orthostatic tachycardia syndrome treated with ivabradine
A 22-year-old woman was referred with exertional dyspnoea and chest tightness 3 weeks following a diagnosis of COVID-19. Evaluation revealed a resting sinus tachycardia and criteria for postural orthostatic tachycardia syndrome were met. After non-pharmacological interventions failed to yield sympto...
Autores principales: | O'Sullivan, Jenna Stephanie, Lyne, Andrew, Vaughan, Carl J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204164/ https://www.ncbi.nlm.nih.gov/pubmed/34127505 http://dx.doi.org/10.1136/bcr-2021-243585 |
Ejemplares similares
-
IVABRADINE EFFECTS ON COVID-19 INDUCED POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME
por: Abdelnabi, Mahmoud, et al.
Publicado: (2023) -
Ivabradine in Postural Orthostatic Tachycardia Syndrome: A Review of the Literature
por: Tahir, Faryal, et al.
Publicado: (2020) -
Potentially New Indication of Ivabradine: Treatment of a Patient with Postural Orthostatic Tachycardia Syndrome
por: Hersi, Ahmad S
Publicado: (2010) -
COVID-19-INDUCED POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME
por: KHAN, ARSHAN
Publicado: (2022) -
Autoimmune postural orthostatic tachycardia syndrome
por: Watari, Mari, et al.
Publicado: (2018)